According to FutureWise analysis the market for Poultry Vaccines in 2023 is US$ 2.04 billion, and is expected to reach US$ 3.68 billion by 2031 at a CAGR of 7.60%.
Vaccines for poultry are widely used to prevent and control contagious poultry diseases. Their use in poultry production is intended to avoid or reduce the emergence of clinical disease at the farm level, thereby increasing production. Vaccines and vaccination programs vary widely depending on several local factors (e.g., type of production, regional disease pattern, costs and potential losses) and are generally managed by the poultry industry. The financial losses caused by the major epidemic diseases of poultry (avian influenza and Newcastle disease) have been enormous in the last decade for both the commercial and public sectors. Vaccination should thus be used in the framework of national or regional poultry disease eradication programs under the official supervision of public veterinary services.
An important part of global agriculture is the poultry industry. Each year, more than 8 billion birds worth more than $20 billion are produced in the US. The majority of the market is made up of broiler chickens. Commercially produced birds are susceptible to a variety of environmental pathogen exposures. As a result, vaccination is a crucial component of flock health management regimens. The current accepted practice in the business is active vaccination utilizing live vaccines. MDV, NDV, IBV, and IBDV are vaccines that are frequently given to hens, whereas NDV and HEV are given to turkeys. Also, being investigated for a commercial application are molecular recombinants, which are vaccines made by putting the genes for immunogenic proteins from infectious organisms into a living viral vector. Adjuvants, notably cytokines, are being used in efforts to increase vaccine efficacy.
Poultry production methods range from small-scale farming to highly industrialized, vertically integrated systems. Domestic, terrestrial, and aquatic chickens are primarily raised in backyard aviaries in most rural and peri-urban areas worldwide. Although intensive poultry farming is most common in developed countries, many developing countries have adopted this technique in recent decades to meet rising animal product demand globalization, as well as the potential persistence and spread of disease agents through domestic and wild reservoirs, have recently increased the risk of transboundary pathogen transmission to highly exposed areas. Vaccines play an important role in preventing and managing poultry diseases worldwide. Their traditional use in poultry production is to prevent or reduce the occurrence of clinical disease at the farm level, resulting in increased productivity. The increased prevalence of disease and the critical use of vaccines to prevent disease transmission will drive the poultry vaccine market during the forecast period. The COVID-19 pandemic has had significant impact on economic and social life. This has also had a negative impact on the poultry market, which has a negative impact on poultry vaccine production. Governments have taken action to prevent the spread of coronavirus, resulting in travel restrictions, border closures, and even a national lockdown, which has hampered the growth of the poultry vaccine market. Poultry is one of India's fastest-growing agricultural sectors, with egg and broiler production increasing at a rate of 8 to 10% per year. As a result, India is now the world's fifth-largest egg producer and the world's eighteenth-largest broiler producer. MSD animal health has continued to develop innovative solutions for poultry problems, such as a line of vaccines that provide long-term protection against the most infectious diseases threatening commercial poultry operations today. One of these is a vaccine that uses DNA viral vaccine technology to prepare the chicken's immune system to recognize and react to a pathogen component, allowing the chicken's body to respond to future infections. In a single vaccination, the vaccine protects chickens at the hatchery against three highly infectious diseases. The development of advanced vaccines to improve poultry production can provide opportunities for key players to enhance their product portfolio and secure a larger customer base in this target market.
FutureWise Market Research has published a report that provides an insightful analysis of poultry vaccine market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, the poultry vaccine market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.